Cost-effectiveness of Oral Protease Inhibitors Co-administration versus Pegylated Interferon-Α2b and Ribavirin Only for the Patients with Hepatitis C Genotype 1 in Kazakhstan Health Care Settings

• Главные авторы: Alima ALMADIYEVA (Автор), Serik IBRAYEV (Автор), Assiya TURGAMBAYEVA (Автор), Alexandr KOSTYUK (Автор), Zayituna KHISMETOVA (Автор), Zhanar AKHMETOVA (Автор)
• Формат: ‌
• Опубликовано: Tehran University of Medical Sciences, 2018-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The triple therapy including peginterferon, ribavirin and protease inhibitors was more effective compared to the combination of only peginterferon and ribavirin. This study aimed to assess the cost-effectiveness of triple treatment in either treatment-naïve and treatment-experienced pat...